A strong correlation exists between the localization of the H3K36me3 mark and the DOT1L (Disruptor of telomere silencing protein 1-like)-dependent H3K79me2 mark in MLL-fusion expressing AML [30,38]. Here, KMT2A is linked to acute myeloid leukemia.